Metabolism Assays Market Size Projected to Reach USD 3.1 Billion by 2034, Growing Steadily at 6.7% CAGR | Report by Transparency Market Research, IncGlobeNewsWire • 08/28/24
Acquisition of Abcam by Danaher Approved by the High Court of Justice of England and WalesBusiness Wire • 12/04/23
Abcam Acquisition by Danaher Has Received All Identified Clearances; Transaction Expected to Close on December 6, 2023Business Wire • 11/17/23
Statement from Dr. Jonathan Milner on the suspension of the “Vote AGAINST” campaignGlobeNewsWire • 11/01/23
Leading Independent Proxy Advisor Glass Lewis Joins ISS in Recommending Shareholders Vote “FOR” Danaher Corporation's Proposed Acquisition of AbcamBusiness Wire • 10/23/23
Leading Proxy Advisor, ISS, Recommends Shareholders Vote “FOR” Danaher Corporation's Proposed Acquisition of AbcamBusiness Wire • 10/17/23
Jonathan Milner releases presentation to Abcam plc shareholders, outlining reasons to reject Danaher's bid and strategic vision for the CompanyGlobeNewsWire • 10/16/23
Exlusive: Why Abcam founder believes Danaher's acquisition offer falls shortProactive Investors • 10/16/23
Independent Directors of Abcam Highlight Compelling Reasons for Shareholders to Support Proposed Sale to DanaherBusiness Wire • 10/12/23
ABCAM INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Abcam plc - ABCMBusiness Wire • 10/10/23
Abcam Files and Mails Scheme Circular Seeking Approval of Acquisition of Abcam by Danaher for $24.00 per ShareBusiness Wire • 10/05/23
Dr. Jonathan Milner opposes Danaher's acquisition of Abcam and calls for EGM to replace BoardGlobeNewsWire • 09/14/23
ABCM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Abcam plc Is Fair to ShareholdersBusiness Wire • 08/28/23
